News + Filings Transactions
|
SCIASCIA THOMAS
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 09/19/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Performance Stock Options (right to buy) | 7.5k | $3.21 | $24.1k | | 09/19/2022 |
| 06/29/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Performance Stock Options (right to buy) | 30k | $3.21 | $96.3k | | 06/29/2022 |
| 02/11/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Stock Option (right to buy) | 110k | $0.51 | $56.2k | | 02/11/2022 |
| 02/11/2022 | Trevi Therapeutics, Inc. | TRVI | Grant | Stock Option (right to buy) | 110k | $0.51 | $56.2k | | 02/11/2022 |
| 02/17/2021 | Trevi Therapeutics, Inc. | TRVI | Grant | Stock Option (right to buy) | 50k | $3.21 | $160.5k | | 02/17/2021 |
| 02/13/2020 | Trevi Therapeutics, Inc. | TRVI | Grant | Stock Option (right to buy) | 60k | $5.50 | $330k | | 02/13/2020 |
| 06/03/2019 | Trevi Therapeutics, Inc. | TRVI | Grant | Stock Option (right to buy) | 50k | $10.12 | $506k | | 06/03/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Series C Preferred Stock | 13.4k | $0.00 | $0 | | 05/09/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Series A Preferred Stock | 109k | $0.00 | $0 | | 05/09/2019 |
| 05/09/2019 | Trevi Therapeutics, Inc. | TRVI | Conversion | Common Stock | 17.1k | $0.00 | $0 | | 05/09/2019 |
|